Mark your calendars for the Ohio VC Fest at the Huntington Convention Center on September 17th! The Factor 7 Medical team is eager to learn from insightful workshops and engage with the vibrant entrepreneurial community in Cleveland. We can't wait to be part of this exciting event! Check out the agenda:?https://lnkd.in/dUm6UxiK
Factor 7 Medical
商务咨询服务
Dayton,OH 1,000 位关注者
FACTOR 7 MEDICAL AMPLIFIES SUCCESS FOR MEDICAL TECHNOLOGY COMPANIES
关于我们
Achieving measurable and sustainable results in healthcare is a challenging process, and having the right resources is imperative. Whether on a fractional, project-based or full-time basis, Factor 7 Medical delivers proven, trusted, and deep expertise that can strengthen your technology, your operations, and your commercial results. Factor 7 provides expert services throughout the entire product lifecycle, from product inception to market launch and sales acceleration. Our services cover new product development, regulatory compliance, marketing, operational leadership, commercialization strategy, and much more. We specialize in navigating the complex medical device market landscape, helping our clients bring their products to market efficiently and effectively. We have a wide network of subject matter experts in various therapeutic applications and technologies, including Orthopedics, Spine, Biologics, Cardiovascular, Pediatrics, and more. We also have access to a range of vetted medical device contract engineering, prototyping, and manufacturing partners to ensure capability alignment. We can accelerate any project and deliver immediate results that you can trust. Factor 7 is unique because of our collective market influence, experience, and expansive network, which has proven successful in the medical industry. Our process involves evaluating your needs, designing a solution, and executing it to achieve desired results. Trust us to provide exceptional results for your medical device needs. For more information please visit our website or email us at [email protected].
- 网站
-
https://www.factor7medical.com
Factor 7 Medical的外部链接
- 所属行业
- 商务咨询服务
- 规模
- 11-50 人
- 总部
- Dayton,OH
- 类型
- 合营企业
- 创立
- 2021
- 领域
- Product Development、Commercial Excellence、Operations、Lifecycle Management、Sales and Marketing、Business Strategy、Hospital Systems、Strategic Planning、Branding、Digital Marketing、Lean Practices、Sourcing and Outsourcing、Mergers and Acquisitions、Financial Performance、Systems Analysis、Intellectual Property、Leadership Development、RA / QA / CA、Project Rescue和Market Research
地点
Factor 7 Medical员工
-
Shaher Ahmad
Medical Devices | Innovation | New Product Development
-
Dan Sands
CEO, COO, Sales, Marketing - Delivering results for medical technology growth stage companies who need help with business strategy, fractional…
-
Andrew Curtis
Creative + Technical Problem Solver / #brand #web #appdev #digitalmarketing #cmo
-
Kevin Haines
Sales and Marketing Professional |Upstream and Downstream Marketing | Commercial Strategy Development | Sales Team Development | General Management /…
动态
-
Factor 7 Medical is excited to welcome Mac Winslow to its team.??With a career highlighted by roles at leading global sales and marketing teams and projects requiring a nuanced understanding of market demands and regulatory landscapes, Mac has proven his ability to deliver results that enhance top and bottom lines. His work includes significant experience with market segmentation, targeting, and positioning, helping businesses effectively reach and engage their desired audiences. ? "From early-stage startups to industry leaders, I've had the opportunity to partner with a diverse range of clients in the life sciences and healthcare sectors. Each engagement has deepened my understanding of the unique challenges and opportunities these industries present. My passion lies in crafting tailored strategies that not only drive growth and efficiency but also empower organizations to fulfill their missions." Go Farther, Faster!
-
Elevate Your Medtech Leadership on September 24th! Join the 4th session of our Ohio Life Sciences Entrepreneur Workshop?series on Sept 24th at 11 AM EST. It's an intensive program designed to equip Entrepreneurs in Residence, CEO in Residence candidates, and Senior Leaders with the skills and strategies to thrive in the competitive medtech market. Gain invaluable insights into clinical research, product development, and regulatory processes. Learn from industry expert Shaher Ahmad, (representing Factor 7 Medical) an accomplished executive with a proven track record in medical device innovation and commercialization. Solidify skills in strategic vision, team building, stakeholder engagement, and more. Don't miss this opportunity to take your medtech leadership to the next level. hashtag #entrepreneurship hashtag #leadership hashtag #medicaldevices
Join us for the 4th session of our OLS Entrepreneur Workshop?series on Sept 24th at 11 AM EST. Learn about:? Clinical research ??? Product development? Regulatory processes? Expert speakers include:? Duane Mancini, M. Sc. (Project Medtech)? Amol Soin (SOIN NEUROSCIENCE, INC.)? William Flickinger (Wave Strategy )? Sean McKibben (Project Medtech)? Andy Schimmoeller (CMD MedTech)? Shaher Ahmad (Factor 7 Medical)? Don’t miss out. Register now!?https://lnkd.in/gyq-ApPg?
OLS EWS: Clinical Research | Product Development | Regulatory Process
eventbrite.com
-
Elevate Your Medtech Leadership on September 24th! ? Join the 4th session of our Ohio Life Sciences Entrepreneur Workshop?series on Sept 24th at 11 AM EST. It's an intensive program designed to equip Entrepreneurs in Residence, CEO in Residence candidates, and Senior Leaders with the skills and strategies to thrive in the competitive medtech market. ? Gain invaluable insights into clinical research, product development, and regulatory processes. Learn from industry expert Shaher Ahmad, (representing Factor 7 Medical) an accomplished executive with a proven track record in medical device innovation and commercialization. Solidify skills in strategic vision, team building, stakeholder engagement, and more. ? Don't miss this opportunity to take your medtech leadership to the next level, register now! https://lnkd.in/gyq-ApPg #entrepreneurship #leadership #medicaldevices
-
Such an amazing technology and group of leaders.
Our CEO, Ofer Shalev, was featured in a recent Jerusalem Post podcast, where he discussed #leadership and #innovative #technology at New Phase. Listen to this #inspiring interview here: https://lnkd.in/da5t53Yq
Meet the Israeli startup using nanotechnology to fight cancer
jpost.com
-
Factor 7 is thrilled to see RoddyMedical, Inc. heading to the Vizient, Inc Innovative Technology Showcase! The SecureMove-TLC? technology sounds like a game-changer for patient safety and hospital efficiency. Looking forward to seeing it in action!
We’re excited to be heading to Vegas and the Vizient, Inc Innovative Technology Showcase in September! Healthcare providers will get the chance to explore exhibit booths, connect with exhibitors and gather information on the latest medical technologies and innovative products at this dynamic, fast-paced, hands-on event. We’ll be showcasing how the SecureMove-TLC? medical line securement technology can help: Prevent Line Pulls & Dislodgements Reduce Dressing Changes & CLABSI Rates Improve Staff Efficiency & Patient Safety Support Early Mobility = Earlier Discharge More info here: https://lnkd.in/eeW8_Epj Event held in conjunction with: https://lnkd.in/g-dKkUTb #lasvegas #healthcare #tech #medtech #hospital #innovation
-
This is a unique chance to make a real difference in people's lives and be part of a groundbreaking investment opportunity. Please take a look at what New Phase is doing to help patients with Stage 4 cancer.
Scientifically Proven and Ready for the Next Step: New Phase Poised to Begin Clinical Trials in the U.S. in Q4-2024 The safety and efficacy of the Sarah Nanotechnology System (SaNP) is backed by rigorous scientific research, including years of extensive benchtop studies, in vitro testing, and preclinical trials under GLP conditions in both small and large animals. The results can be seen in our manuscripts. A feasibility clinical trial is ongoing (results expected Q3-2024), with 21 patients treated, indications of tumor shrinkage or stable disease, and no reported device-related SAEs (serious adverse events) or toxicity, including patients that received repeated treatments. With U.S. FDA Investigational Device Exemption (IDE), New Phase has opportunities for you to invest in a proven company, proven treatment, and the development of life-saving cancer treatment. Check out our scientific publications presenting our deep science knowledge and achievements - https://lnkd.in/d84ms47k ? Interested in being part of a proven company, proven treatment, and the development of life-saving cancer treatment? Contact Email [email protected] or DM Irie Meltzer, our VP Business Development. Ofer Shalev,?Sarah Kraus?? #CancerResearch #ScientificInnovation #ClinicalTrials #MedTech #NewPhase
-
Investing in Hope: Join New Phase in Changing the Lives of Patients with Stage IV Cancer ? New Phase has been approved to start #IDE studies in the U.S. with its Sarah Nanotechnology System – an innovative system that utilizes #nanoparticles and #electromagnetic energy to destroy malignant cells and preserve healthy ones. Early clinical trials show promising results towards changing the future of cancer and making a real difference in the lives of those affected by this devastating disease. Investment opportunities are available – contact New Phase for more information. ? Interested in being part of potential business success of a medical breakthrough that could save and enhance countless lives? Contact Email [email protected] or DM Irie Meltzer, our VP Business Development. ? #ImpactInvesting #MedTech #CancerResearch #NewPhase
-
Factor 7 Medical is excited to welcome Jeff Stebbins, M.B.A. to its team. With over 20 years of experience in the medical device industry, Jeff has worked with some of the largest companies in the world. His professional expertise spans market research, market access, and marketing for both existing and new technologies. He is known for developing innovative marketing plans that efficiently drive business growth. “I am passionate about helping companies leverage data-driven insights to optimize marketing efforts. My strategic mindset and creative problem-solving skills enable me to develop innovative marketing solutions that resonate with target audiences to drive business objectives. By continually driving business growth through analysis and innovation, I ensure that I remain at the forefront of the ever-evolving marketing landscape”. Bob Peterhans Dan Sands Kevin Haines Mark Shaker Mike Wentz, M.S. Shaher Ahmad Becca Kiel John D. Mark Bergman Jeff Stebbins, M.B.A.
-
?? Couldn't agree more! This is what the startup community is all about – lifting each other up and building success together. Huge congrats to Cohort 5 of the Capital Readiness Program! It's inspiring to see founders taking the steps to scale their businesses and make a real impact.
Abide by startup karma: Do business with each other. Do business for each other. ?? That’s one of the rules of engagement for our Capital Readiness Program. With Cohort 5 wrapping up today, we’re grateful to the 10 startups who focused, decelerated, and committed to transitioning from being task-oriented founders to CEOs equipped to engage with sophisticated investors, raise capital, and scale their businesses. ?? Thank you to our dedicated Investors-in-Residence who carved out 5 days to work alongside the cohort, offer invaluable guidance, and open up their networks to the startups. ?? The program wouldn’t be nearly as comprehensive without the participation of our subject matter experts who provided an added depth of knowledge into all aspects that touch health tech startups. ? ? And last but certainly not least, thank you to Cozen O'Connor for sponsoring Cohort 5 of the Capital Readiness Program. ?? Startups: Calla Lily Clinical Care, CygnusMed, Inc., Dama Health, DriQ Health, Four-Forty, Hibiscus Health, InnoTech Precision Medicine, Inc. Kuana, ThirdLaw Molecular LLC, Voythos ?? Investors-in-Residence: Dan Sands of Factor 7 Medical, Julien L. Pham, MD, MPH of 3CC | Third Culture Capital, Vanessa Villaverde of California Health Care Foundation, Kim Frazier of EC Angels via Entrepreneurs' Center, Anish Srivastava of Telosity Ventures ?? Subject Matter Experts: Baker Tilly US, Cozen O’Connor, Duane Morris LLP, Independence Blue Cross, KPMG, NIH SEED, Layer 8 Security, PitchBook, Virtua